Mercury Labs profit dives 69% in Q1 as revenue slips 12%
Net profit plunges to ₹29.78 lakh from ₹96.76 lakh a year ago; auditors issue unmodified report.
— 1 earlier story on Mercury Laboratories Ltd. →What's new
- Revenue fell 12% YoY to ₹15.96 crore in Q1 FY27.
- Net profit dropped 69% to ₹29.78 lakh from ₹96.76 lakh.
- Auditors gave an unmodified report on the unaudited results.
Why this matters
For a nano-cap pharma with a ₹98 crore market cap, a 69% profit crash signals serious near-term pressure on margins or demand. The lack of management commentary means investors have no explanation beyond the bare numbers.
What we're watching
- Whether Q2 shows any recovery or further deterioration.
- Any cost or revenue guidance from management in the next call.
- Impact on the stock's already thin liquidity at current market cap.
The full read
Mercury Laboratories reported a brutal first quarter. Net profit plunged 69% to ₹29.78 lakh from ₹96.76 lakh a year earlier, on a 12% revenue decline to ₹15.96 crore. The auditors issued a clean report (no qualification) but the absence of management commentary leaves investors guessing. For a nano-cap pharma with a ₹98 crore market cap and a trailing P/E of 20x, this kind of earnings contraction raises real questions about demand and cost control. The next quarter will tell if this was a one-off or the start of a trend.
Questions answered
- What caused Mercury's sharp profit decline?
- The filing does not provide a reason. The company only reported the numbers without commentary, so the drop could be from seasonal weakness, higher costs, or lower realizations.
- Is the auditor's report clean?
- Yes. The statutory auditors conducted a limited review and issued an unmodified (clean) report, meaning no red flags in the accounting.
- How does Mercury's valuation look after this quarter?
- With a trailing P/E of 20.2x and market cap of ₹98 crore, the stock still trades at a premium to its earnings base, which just shrank 69%.
- Did the board declare a dividend or buyback?
- No. The board only approved the quarterly results; no dividend or other corporate action was announced.
Mercury Laboratories Ltd.
Latest quarter · Jun 2026
Strength & growth
Story so far
All notes on MERCURYLAB →- 25 Jul 2026 · 12:17 PM IST Mercury Labs profit dives 69% in Q1 as revenue slips 12%
- 3d ago Mercury Labs net profit plunges 69% as revenue slips in Q1